Chinese Studies

Vol.2 No.3(2013), Paper ID 35535, 6 pages

DOI:10.4236/chnstd.2013.23020

 

Financing Innovative Medicines in Mainland China: The Role of Commercial Health Insurance

 

Hong Li, Gordon G. Liu, Christoph Glaetzer

 

Bristol-Myers Squibb Company, Wallingford, USA
Peking University, Beijing, China
Janssen Pharmaceutical Companies of Johnson & Johnson, Singapore City, Singapore

 

Copyright © 2013 Hong Li, Gordon G. Liu, Christoph Glaetzer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Li, H. , Liu, G. and Glaetzer, C. (2013) Financing Innovative Medicines in Mainland China: The Role of Commercial Health Insurance. Chinese Studies, 2, 128-133. doi: 10.4236/chnstd.2013.23020.

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.